Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 120202-66-6
Drug Levels and Effects
Summary of Use during Lactation
Information from two mothers indicates that minute quantities of clopidogrel and its metabolites are excreted into milk and one breastfed infant had trivial serum levels. Two mothers and the manufacturer reported that no adverse effects have been observed in breastfed infants with maternal clopidogrel use during lactation in two cases. If a mother requires clopidogrel, it is not a reason to discontinue breastfeeding, but monitor the infant for bruising or bleeding.
Drug Levels
Maternal Levels. Milk samples were obtained over a 24-hour period from two nursing mothers who were taking clopidogrel 75 mg daily. In the first patient, milk collections were done at 7 and 9 months postpartum. At 220 days months postpartum, clopidogrel concentrations ranged from 0.03 to 1.11 mcg/L, clopidogrel carboxylic acid concentrations ranged from 1.5 to 22.44 mcg/L and clopidogrel active metabolite concentrations were below the limit of quantification (<0.008 mcg/L). At 288 days postpartum, clopidogrel concentrations ranged from 0.42 to 10.46 mcg/L, clopidogrel carboxylic acid concentrations ranged from 1.25 to 36.32 mcg/L and clopidogrel active metabolite concentrations were below the limit of quantification (<0.008 mcg/L) in 5 samples and 0.18 mcg/L in 1 sample. In the second patient, milk samples taken at 435 days postpartum, clopidogrel concentrations ranged from 0.02 to 1.69 mcg/L, clopidogrel carboxylic acid concentrations ranged from 1.43 to 26.96 mcg/L and clopidogrel active metabolite concentrations were below the limit of quantification (<0.008 mcg/L). Relative infant dosages averaged 0.008% for clopidogrel and 0.071% when the two metabolites were included.[1]
Infant Levels. An infant aged 14 months was partially breastfed by a mother taking clopidogrel 75 mg daily. A blood sample was obtained from the infant. The concentrations in the infant blood sample were clopidogrel <0.01 mcg/L, CAMD <0.01 mcg/L, and clopidogrel carboxylic acid 0.05 mcg/L.[1]
Effects in Breastfed Infants
Two infants aged 7 to 14 months were partially breastfed by mothers taking clopidogrel 75 mg daily. No adverse health issues were reported for either infant by their mothers.[1]
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- Van Neste M, Nauwelaerts N, Mols R, et al. Clopidogrel transfer into human milk: Case series – a contribution from the ConcePTION project. Front Pharmacol 2025;16:1499243. [PMC free article: PMC11996768] [PubMed: 40235546]
Substance Identification
Substance Name
Clopidogrel
CAS Registry Number
120202-66-6
Drug Class
Breast Feeding
Milk, Human
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PMCPubMed Central citations
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Cannabis.[Drugs and Lactation Database (...]Review Cannabis.. Drugs and Lactation Database (LactMed®). 2006
- Review Melatonin.[Drugs and Lactation Database (...]Review Melatonin.. Drugs and Lactation Database (LactMed®). 2006
- Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.[Cochrane Database Syst Rev. 2011]Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Cochrane Database Syst Rev. 2011 Jul 6; (7):CD003510. Epub 2011 Jul 6.
- Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.[Cochrane Database Syst Rev. 2007]Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Cochrane Database Syst Rev. 2007 Jan 24; (1):CD003510. Epub 2007 Jan 24.
- Supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby.[Cochrane Database Syst Rev. 2016]Supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby.Abe SK, Balogun OO, Ota E, Takahashi K, Mori R. Cochrane Database Syst Rev. 2016 Feb 18; 2(2):CD010647. Epub 2016 Feb 18.
- Clopidogrel - Drugs and Lactation Database (LactMed®)Clopidogrel - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...